-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2020.pdf
January 01, 2020 - 3 54 Chronic pulmonary disease
19 CMR_OBESE Num 3 57 Obesity
20 CMR_PERIVASC Num 3 60 Peripheral vascular
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2024-medical-office-database-report-rev.pdf
January 01, 2024 - Pulmonary Medicine 20 2%
Radiology 3 <1%
Rheumatology 11 1%
Surgery (All) 45 4%
Urology 16 2%
Vascular
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2021.pdf
January 01, 2021 - Chronic pulmonary disease
564 CMR_OBESE Num 3 1686 Obesity
565 CMR_PERIVASC Num 3 1689 Peripheral vascular
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2021.pdf
January 01, 2021 - Chronic pulmonary disease
564 CMR_OBESE Num 3 1686 Obesity
565 CMR_PERIVASC Num 3 1689 Peripheral vascular
-
www.ahrq.gov/sites/default/files/wysiwyg/sops/surveys/medical-office/2022-mosops-database-report-part-I.pdf
January 01, 2022 - Pulmonary Medicine 21 2%
Radiology 2 <1%
Rheumatology 9 1%
Surgery (All) 56 6%
Urology 19 2%
Vascular
-
hcup-us.ahrq.gov/db/nation/nass/stats/NASS_Summary_Stats_DX_PR_GRPS_Weighted_2022.pdf
January 01, 2022 - 3 54 Chronic pulmonary disease
19 CMR_OBESE Num 3 57 Obesity
20 CMR_PERIVASC Num 3 60 Peripheral vascular
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2020.pdf
January 01, 2020 - 3 54 Chronic pulmonary disease
19 CMR_OBESE Num 3 57 Obesity
20 CMR_PERIVASC Num 3 60 Peripheral vascular
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_weighted_2019.pdf
January 01, 2019 - 3 54 Chronic pulmonary disease
20 CMR_OBESE Num 3 57 Obesity
21 CMR_PERIVASC Num 3 60 Peripheral vascular
-
hcup-us.ahrq.gov/db/nation/nass/stats/nass_summary_stats_dx_pr_grps_unweighted_2019.pdf
January 01, 2019 - 3 54 Chronic pulmonary disease
20 CMR_OBESE Num 3 57 Obesity
21 CMR_PERIVASC Num 3 60 Peripheral vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
January 01, 2024 - , habitual WG consumption <24 g/d Diabetes, heart, renal, bowel, liver, pancreatic, inflammatory or vascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
January 01, 2024 - , habitual WG consumption <24 g/d Diabetes, heart, renal, bowel, liver, pancreatic, inflammatory or vascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary19/high-blood-pressure-in-adults-screening-monitoring-october-2015
December 22, 2014 - Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Resistive exercise versus resistive
vibration exercise to counteract vascular
adaptations to bed rest
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
November 01, 2012 - conditions with symptoms that mimic RLS (e.g., periodic
leg movement disorders, nocturnal leg cramps, vascular
-
hcup-us.ahrq.gov/reports/methods/Comparison_Report_NIS61997Final.pdf
August 09, 2000 - pleura,
thoracentesis, chest
drainage
22 169: Debridement of
wound, infection or burn
20 54: Other vascular
-
www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-PUF-Summary-Statistics-Commercial-Outpatient-Weighted.pdf
September 26, 2023 - included Independent Diagnostic Testing
Facilities (IDTF)
10,674 0.01 11,539,821 5.89
76: Peripheral vascular
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
September 03, 2019 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
April 15, 2013 - Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure-future_research.pdf
August 01, 2012 - in individuals at increased cardiovascular risk,
based on the presence of the combination of either vascular
-
www.ahrq.gov/sites/default/files/publications/files/confidreportguide_0.pdf
March 01, 2016 - HPMG, which set an
improvement goal of having 62 percent of a clinic’s patients achieve the optimal vascular